Vincerx Pharma, Inc.

NASDAQ (USD): Vincerx Pharma, Inc. (VINC)

Last Price

0.263

Today's Change

-0.062 (19.07%)

Day's Change

0.259 - 0.328

Trading Volume

15,866,965

Overview

Market Cap

9 Million

Shares Outstanding

36 Million

Avg Volume

6,416,036

Avg Price (50 Days)

0.28

Avg Price (200 Days)

0.99

PE Ratio

-0.31

EPS

-0.86

Earnings Announcement

27-Mar-2025

Previous Close

0.33

Open

0.33

Day's Range

0.2585 - 0.3283

Year Range

0.175 - 9.372

Trading Volume

15,866,965

Price Change Highlight

1 Day Change

-19.14%

5 Day Change

45.19%

1 Month Change

-9.07%

3 Month Change

-62.10%

6 Month Change

-64.34%

Ytd Change

0.00%

1 Year Change

-77.73%

3 Year Change

-97.48%

5 Year Change

-97.19%

10 Year Change

-97.19%

Max Change

-97.19%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment